Xlife Sciences Ltd. header image

Xlife Sciences Ltd.

XLS

Equity

ISIN CH0461929603 / Valor 46192960

SIX Swiss Exchange (2026-04-24)
CHF 21.30+4.93%

Xlife Sciences Ltd.
UMushroom community rating:

star star star star star
3.50 2 votes No rating yet
NegativeNeutralPositive

About company

The provided company page did not include substantive text, so based on the company name and typical activity in the sector, Xlife Sciences Ltd. is a life‑sciences firm that develops and commercializes health‑related products and services; its business is likely centered on research and development, regulatory interactions and the manufacture or outsourcing of pharmaceuticals, diagnostics or nutraceuticals, with commercial efforts focused on licensing, partnerships and product sales to healthcare providers, distributors and consumers. As with similar small‑to‑mid‑sized life‑sciences companies, value depends on the progress of its development pipeline, regulatory approvals, strategic collaborations and its ability to secure funding and scale manufacturing and distribution.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-16.1%1Y
-33.0%3Y
-56.2%5Y

Performance

62.2%1Y
63.4%3Y
58.8%5Y

Volatility

Market cap

156 M

Market cap (USD)

Daily traded volume (Shares)

7,394

Daily traded volume (Shares)

1 day high/low

25.9 / 24.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.50

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Timo R
Switzerland, 16 Apr 2025
star star star star star
.
Raphael Raufer
Switzerland, 16 Apr 2025
star star star star star
Leider schlechte Performance im Moment

EQUITIES OF THE SAME SECTOR

Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.10%USD 31.57
Addus HomeCare Corp
Addus HomeCare Corp Addus HomeCare Corp Valor: 10385048
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.32%USD 95.71
Sareum Holdings PLC
Sareum Holdings PLC Sareum Holdings PLC Valor: 116566624
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.38%GBP 0.20
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.85%USD 22.08
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.99%USD 22.42
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.10%CHF 84.52
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.74%USD 24.10
medmix Ltd
medmix Ltd medmix Ltd Valor: 112967710
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.80%CHF 8.64
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%CHF 281.40
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 1.05